OPEN TB | Sessão 2: Scientific and Policy Considerations

“Scientific considerations regarding inclusion of PDL in clinical trials of TB vaccines” – Alberto L. García-Basteiro, Barcelona Institute for Global Health/ Hospital Clinic – Universitat de Barcelona

“TB vaccine models and PDL” – Richard White, London School of Hygiene & Tropical Medicine

“How should PDL be considered in the global strategy for TB vaccine introduction” – Birgitte Giersing
Vaccine Product & Delivery Research, Dept. of Immunization, Vaccines & Biologicals

“Considerations for PDL in the national strategy for TB control in Brazil” – Ethel Maciel, Secretariat of Health/ Surveillance and Environment of the Ministry of Health

Saiba mais sobre como a pesquisa em TB está avançando, trazendo novas perspectivas para o tratamento e inclusão de populações vulneráveis.